Alpine Select AG Share Price

Equities

ALPN

CH0019199550

Investment Management & Fund Operators

Market Closed - Swiss Exchange 16:31:30 26/04/2024 BST 5-day change 1st Jan Change
7.7 CHF -1.91% Intraday chart for Alpine Select AG -2.53% -1.91%

Financials

Sales 2022 1.62M 1.77M 142M Sales 2023 5.72M 6.25M 501M Capitalization 68.37M 74.76M 5.99B
Net income 2022 -28M -30.62M -2.45B Net income 2023 - 0 0 EV / Sales 2022 58.6 x
Net cash position 2022 12.44M 13.6M 1.09B Net cash position 2023 5.03M 5.5M 441M EV / Sales 2023 11.1 x
P/E ratio 2022
-3.71 x
P/E ratio 2023
-163 x
Employees 3
Yield 2022
8.26%
Yield 2023
-
Free-Float 31.86%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.91%
1 week-2.53%
1 month-1.91%
3 months+2.67%
6 months+5.48%
Current year-1.91%
More quotes
1 week
7.50
Extreme 7.5
7.90
1 month
7.05
Extreme 7.05
7.90
Current year
7.05
Extreme 7.05
8.00
1 year
6.90
Extreme 6.9
12.00
3 years
6.90
Extreme 6.9
15.70
5 years
6.90
Extreme 6.9
15.70
10 years
6.90
Extreme 6.9
19.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 30/06/13
Chief Operating Officer - 30/04/18
Chief Investment Officer 66 21/05/17
Members of the board TitleAgeSince
Chairman 64 24/04/13
Director/Board Member 62 31/12/11
Chief Investment Officer 66 21/05/17
More insiders
Date Price Change Volume
26/04/24 7.7 -1.91% 100
25/04/24 7.85 0.00% 100
24/04/24 7.85 +4.67% 10,009
23/04/24 7.5 -5.06% 3,229
22/04/24 7.9 0.00% 0

Delayed Quote Swiss Exchange, April 26, 2024 at 04:31 pm

More quotes
Alpine Select AG (Alpine) is a Switzerland-based investment company. The Company's emphasis lies on securities, quoted or otherwise, of Swiss and foreign corporations, which are subject to particular corporate events such as spin-offs, acquisitions, recapitalizations and reorganizations, or circumstances including valuation anomalies or technical market situations. Alpine Select AG’s investment portfolio is primarily comprised of quoted securities. As of December 31, 2011, the Company’s investments included Absolute Invest AG, Absolute Private Equity AG, AIRE GmbH & Co KGaA, Atrium V Ltd, BB Biotech AG and HBM Bioventures AG, among others. The Company operates through its wholly owned subsidiary, Sumara AG.
More about the company